Kommentar
Moving Toward Minimally Invasive Treatments and Better Risk Characterization for Pilonidal Disease
JAMA Surgery · 2024
DOI: 10.1001/jamasurg.2023.4406 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Surgery, 2024. Verfasst von Pankaj Garg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Garg Fistula Research Institute, Panchkula, India. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Pilonidal Sinus. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Neoplasm Recurrence, LocalPilonidal SinusHumansMinimally Invasive Surgical ProceduresTreatment OutcomeRecurrence
Autor:innen und Institutionen
- Garg Fistula Research Institute, Panchkula, India.
- ESI Hospital, Delhi, India.
Zitieren
APA
Garg, P., & Hemrajani, P. (2024). Moving Toward Minimally Invasive Treatments and Better Risk Characterization for Pilonidal Disease. JAMA Surgery. https://doi.org/10.1001/jamasurg.2023.4406
Vancouver
Garg P, Hemrajani P. Moving Toward Minimally Invasive Treatments and Better Risk Characterization for Pilonidal Disease. JAMA Surgery. 2024. doi:10.1001/jamasurg.2023.4406
BibTeX
@article{Garg2024,
author = {Garg, Pankaj and Hemrajani, Priyanka},
title = {Moving Toward Minimally Invasive Treatments and Better Risk Characterization for Pilonidal Disease},
journal = {JAMA Surgery},
year = {2024},
doi = {10.1001/jamasurg.2023.4406}
}
EUVIMED